This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Lupin, Inc., Ranbaxy Laboratories, Inc.. Active years: 2010-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Delhi, IN (2010)
- Pune, IN (2016)
Company Filing History:
Years Active: 2010-2016
Title: Gagan Kukreja: Innovator in Pharmaceutical Chemistry
Introduction
Gagan Kukreja is a notable inventor based in Pune, India, recognized for his significant contributions to the field of pharmaceutical chemistry. With two patents to his name, he has demonstrated an impressive capacity for innovation, particularly in the development of compounds aimed at treating various serious medical conditions.
Latest Patents
Kukreja's latest patents include groundbreaking research on Tetrahydroquinazolinone derivatives as PARP inhibitors. This invention discloses compounds that play a critical role in pharmaceutical compositions targeting diseases such as cancer by inhibiting the PARP enzyme, thus preventing disease progression.
Another key patented innovation involves inhibitors of phosphodiesterase type-IV. This invention details isoxazoline derivatives that serve as selective inhibitors of PDE type IV, proving beneficial in the treatment of a multitude of ailments, including AIDS, asthma, and chronic obstructive pulmonary disease (COPD). The compound's versatility positions it as a promising therapeutic solution for various inflammatory diseases.
Career Highlights
Throughout his career, Gagan Kukreja has made impactful strides by working with esteemed companies like Ranbaxy Laboratories, Inc. and Lupin, Inc. His experience in these organizations has allowed him to harness his expertise in drug development and innovation within the pharmaceutical industry.
Collaborations
Kukreja's work has involved collaborations with notable professionals in the field, including Venkata Poornapragnacharyulu Palle and Sarala Balachandran. These partnerships have contributed to the successful development of his patented inventions, showcasing the collaborative spirit prevalent in the realm of pharmaceutical research.
Conclusion
Gagan Kukreja stands out as an inventive force in the pharmaceutical sector, with his patents reflecting a dedication to improving health outcomes through innovative solutions. His work exemplifies the critical intersection of science, innovation, and collaborative effort, paving the way for advancements in medical treatments that could greatly benefit society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile